The pet care market offers moderate but stable growth prospects, helped by a constant rise in pet ownership and increase in spending per pet. Currently estimated to be worth over USD 190 billion, researchers expect the global market to grow by an average of close to 5% per year between 2019 and 2025.
The main drivers of this growth are the rise in pet ownership worldwide and a consistent increase in spending per pet, resulting from – for example – an increased spending on fresher and healthier food or the growing prevalence of zoonotic diseases, which is driving up animal healthcare expenses. Another key factor is that owners increasingly treat their loyal companions like family members, with all the perks and benefits this brings.
Pet owners increasingly treat their loyal companions like family members, with all the perks and benefits this brings
In addition to moderate growth prospects, the pet care market also features a relatively resilient profile. In the US, for example, pet care spending continued to grow even during the 2008-09 financial crisis (see Figure 1). The sector encompasses a number of strong, defensive brands and, despite some recent mergers and acquisitions, remains relatively fragmented. Further consolidation is likely.
The US is by far the largest pet care market globally, with an estimated USD 95.7 billion spent in 2019, up 5.7% from 2018. This year, the US pet care market is expected to continue growing, albeit at a slower pace than in previous years. Industry experts estimate that pet-related spending will increase by another 3.5% in 2020 and reach USD 99 billion by the end of the year.
Other smaller but significant markets include large developed European countries such as Germany, the UK and France. Outside the US and Europe, pet ownership levels remain much lower. However, some countries are catching up fast. For instance, the Chinese pet care market is expected to grow by over 14% per year on average between 2019 and 2025, helped by the rapid rise in pet ownership.
In recent years, the rapid increase in pet care spending in large developed markets such as the US, the UK, Germany and France has also been accompanied a surge in demand from newer and more dynamic markets, particularly in Asia. Emerging countries such as China, South Korea and India have seen their pet populations grow rapidly, with pet care spending growing even faster in most cases.
The pet population of South Korea, for instance, grew from 4.9 million in 2014 to 7.5 million in 2018, which is a compound annual rate of 10.8%. Meanwhile, the number of cat and dog owners in China is estimated to have risen by 8.4% from 2018 to 2019, reaching 61.2 million. While this may look like a large number, it is still only a tiny fraction of the country’s overall population.
In many countries, millennials are increasingly seeing pets as a genuine alternative to children. In the US, for example, they represent the largest demographic group of pet owners for all pet types. The APPA defines millennials as being born between 1980 and 1994. Although pets require some investment, they generally cost less and require less dedication than children.
Finally, another interesting recent development has been the emergence of new types of offerings, in particular from the online retail sector. Subscription deals for regular food shipments, such as Chewy.com’s “Autoship” offering, and birthday gift boxes are a case in point. These have given an additional boost to the rise of ecommerce in the pet care segment.
As the Covid-19 crisis unfolds, the key question for investors is whether the increase in pet care spending will change. For now, the short-term effects of the pandemic have been mixed. Containment measures have forced many veterinary practices to remain closed for weeks. The closure of adoption centers in some countries could also slow the rise in pet ownership.
Yet the situation is not homogenous across geographies. While many European countries have kept their animal shelters closed for adoption, shelters in the US have remained open and been emptying as people confined to their homes have been adopting or fostering animals en masse. A similar phenomenon seems to have taken place in other countries, including Australia.
These developments bode well for future spending as a higher proportion of the expenditure is incurred during the initial years, on things like vaccinations. This could be a tailwind for the veterinary sector, offsetting part of the initial disruptions. While it is still too early to draw conclusions, it is clear that the impact of Covid-19 will not necessarily be negative in the short term and may well be positive in the longer term, as well.
The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients.
The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA).
Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile.
Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports.